The attainment of the global mandates presented through the United
Nations Millennium Declaration, September 2000, and the identification
of two priority public health targets (on the one hand HIV/AIDS, malaria,
and other major diseases; and on the other the reduction of child
mortality), will require access to essential public health supplies.
PAHO Strategic Lines of Action
In accordance with the resolution of the Directing Council,
PAHO aims to focus on determinants of access and address key issues
in the selection and supply of public health commodities in priority
diseases within the Region, focusing on three strategic lines of action:
• In the development of national pharmaceutical policy, promoting
coherent generic drug policy as a means to increase the availability
and use of quality essential medicines.
• Developing cost containment strategies for Essential
Public Health Supplies, with focus on two areas: pricing and intellectual
property.
• Strengthening public health commodity supply
systems to ensure continuity and availability.